Carbon 11-labeled pittsburgh compound B positron emission tomographic amyloid imaging in patients with APP locus duplication

Archives of Neurology
Anne M RemesJ O Rinne

Abstract

To investigate amyloid accumulation by carbon 11-labeled Pittsburgh Compound B (11C-PiB) in hereditary cerebral amyloid angiopathy and APP locus duplication. Positron emission tomography with 11C-PiB and magnetic resonance imaging were performed for 2 patients, 49-year-old and 60-year-old siblings with APP locus duplication, with hereditary Alzheimer disease and cerebral amyloid angiopathy. Change in 11C-PiB uptake. Uptake of 11C-PiB was increased especially in the striatum (caudate nucleus to 225% and 280% of the control mean and putamen to 166% and 185% of the control mean) and in the posterior cingulate (to 168% and 198% of the control mean), and it was marginally increased in other cortical brain areas. The pattern of increased 11C-PiB uptake was different from that seen in sporadic Alzheimer disease. Amyloid imaging with 11C-PiB positron emission tomography is a useful tool for detecting in vivo amyloid accumulation in patients with hereditary cerebral amyloid angiopathy. However, the pattern of 11C-PiB accumulation differs between patients with typical AD and patients with APP locus duplication.

Citations

Dec 6, 2014·Neuroimaging Clinics of North America·José LeiteCarlos Alberto Buchpiguel
Sep 5, 2008·Alzheimer Disease and Associated Disorders·William E Klunk, Chester A Mathis
Nov 8, 2008·Current Opinion in Neurology·William E Klunk, Chester A Mathis
May 30, 2009·Current Opinion in Neurology·William Jagust
May 2, 2009·European Journal of Nuclear Medicine and Molecular Imaging·Giovanni Lucignani
Dec 25, 2009·European Journal of Nuclear Medicine and Molecular Imaging·Kjell NågrenJuha O Rinne
Feb 10, 2010·European Journal of Nuclear Medicine and Molecular Imaging·Timo SuotunenJuha O Rinne
Jan 19, 2010·Annals of Nuclear Medicine·Alexander Drzezga
Oct 3, 2012·Seminars in Nuclear Medicine·Chester A MathisWilliam E Klunk
May 10, 2011·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Jeffrey L Cummings
Dec 11, 2008·Annals of Neurology·Steven M GreenbergKeith A Johnson
Sep 13, 2015·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Tiina AnnusAnthony J Holland
Feb 23, 2013·Neurobiology of Aging·Michela PievaniGiovanni B Frisoni
Jun 17, 2015·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Patrick J LaoBradley T Christian
Oct 30, 2012·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Benjamin L HandenWilliam E Klunk
Mar 20, 2012·Cell·Yadong Huang, Lennart Mucke
Nov 24, 2011·Biochimica Et Biophysica Acta·Andrei G VlassenkoJohn C Morris
Mar 17, 2010·Proceedings of the National Academy of Sciences of the United States of America·Lisa MosconiMony J de Leon
Jun 16, 2018·Biomarkers in Medicine·Nicholas J AshtonHenrik Zetterberg
Jun 26, 2012·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·Liyong WuSerge Gauthier
Jan 26, 2021·Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring·Matthew D ZammitBradley T Christian
Jan 24, 2021·Seminars in Nuclear Medicine·Natasha KrishnadasChristopher C Rowe
Sep 3, 2010·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Ahmadul Kadir, Agneta Nordberg
Jun 29, 2021·NeuroImage. Clinical·Matthew D ZammitBradley T Christian
Jul 30, 2021·Frontiers in Aging Neuroscience·Jose L MartinezAnita Bhattacharyya

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Neuroimaging

Neuroimaging can help identify pathological hallmarks of Alzheimer's disease (AD). Here is the latest research on neuroimaging modalities, including magnetic resonance imaging and positron emission tomography, in AD.

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.